Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

CHO · Predicate Candidate Screening

6 FDA 510(k) clearances under this product code; the 50 most recent screened below.

65 daysmedian FDA review time
133 days90th percentile
6clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K860253AMERLEX-M CAMP(125)ASSAY SYSTEM RPA.508 (100 KIT)Amersham Corp.1986-03-14490
K844135PLASMA CYCLIC ADENOSINE MONOPHOSPHATE BY RADIOIMMUImmuno Nuclear Corp.1985-03-051330
K841478RIANEN CYCLIC-AMP RADIOIMMUNOASSAYNew England Nuclear1984-06-14660
K823504CYCLIC ADENOSINE MONOPHOSHATE BY RADIOImmuno Nuclear Corp.1983-01-28650
K811746KING DIAGNOSTICS CHOLESTEROL-FE TESTKing Diagnostics, Inc.1981-07-10180
K811273CYCLIC AMP RADIOIMMUNOASSAY KIT [125I]Bd Becton Dickinson Vacutainer Systems Preanalytic1981-05-27200

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda